#USA #BD #Franklin Lakes #FACSDiscover #Cell Analyzers

BD Launches Cutting-Edge Cell Analysers

BD (Becton, Dickinson and Company), a prominent global medical technology entity, has recently announced the worldwide launch of its latest cell analyzers, the BD FACSDiscover™ A8. These state-of-the-art devices feature remarkable spectral and real-time imaging technology, making them accessible to laboratories of all sizes, from academic institutions to pharmaceutical and biotechnology firms.

The new configurations of the BD FACSDiscover™ A8 Cell Analyzers utilize the revolutionary BD SpectralFX™ Technology, which allows researchers to analyze over 50 attributes of a single cell with remarkable resolution and sensitivity. Furthermore, the BD CellView™ Image Technology ensures high-speed imaging capabilities, providing significant insights into the spatial and morphological characteristics of cells. This enables scientists to visualize where proteins are located within individual cells, which can greatly enhance their experimental outcomes and understanding.

With the introduction of these three- and four-laser configurations, researchers now have a wider range of options to meet their specific needs. Earlier this year, BD launched a five-laser model, and these new additions complement the existing portfolio, reinforcing BD's position as an industry leader in cell analysis technology. Labs can now take advantage of flexible trial options, starting with an introductory phase of the CellView™ Image Technology that can be upgraded over time, aligning seamlessly with evolving research requirements.

Gert Van Isterdael, head of VIB Flow Core Ghent, remarked on the profound impact of the BD FACSDiscover™ A8 on their flow cytometry operations. He stated, "Once you experience the integration of spectral and imaging data, you don't want to go back. It opens a new dimension for our work, helping us see more, understand faster, and enable discoveries that simply weren't possible before." He emphasized that expanding the available configurations will make this cutting-edge technology more accessible to a diverse range of laboratories.

All models of the BD FACSDiscover™ A8 Cell Analyzer are designed with high-throughput capabilities, allowing for efficiency in data gathering and real-time imaging annotations. The intuitive software guiding the analyzers facilitates the management of extensive datasets, making it user-friendly. Moreover, these analyzers work well within the broader ecosystem of BD's offerings, including the BD FACSDiscover™ Cell Sorters and the range of BD Reagents, such as the innovative BD Horizon RealViolet™ 828 and RealBlue™ 824 fluorochromes.

Steve Conly, the worldwide president of BD Biosciences, commented on the significance of providing labs with access to advanced technologies that emphasize flexibility and adaptability spanning across various stages of scientific inquiry. He noted that having more entry points into the BD ecosystem, which now includes cell sorters, reagents, and informatics, gives organizations of all sizes the ability to embrace leading-edge technology in their cell analysis endeavors.

The BD FACSDiscover™ A8 Cell Analyzers are now on the market, with local sales representatives ready to assist labs interested in upgrading their research capabilities. For laboratories constrained by budgetary limitations, BD is offering flexible financing options to make these state-of-the-art tools more attainable. More detailed information can be found at bdbiosciences.com.

About BD

BD stands as one of the largest medical technology firms in the world, dedicated to advancing health through innovative medical discoveries, diagnostics, and healthcare delivery solutions. With a dedicated workforce exceeding 70,000 employees, BD is committed to enhancing care delivery processes, enabling laboratory scientists in disease detection, and supporting researchers as they develop future diagnostics and therapeutics. BD operates in nearly every country and collaborates with various organizations to tackle pressing global health challenges. For further insights about BD, visit their official site or connect on social media platforms.